NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working.
|
|
Join the NPC team for a discussion with Neal Maskrey, Director of Evidence-Based Therapeutics and Andy Hutchinson, Education and Development Manager around three studies:
- Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease: the TIPS study (Lancet)
- Rosuvastatin venous thromboembolism, a secondary outcome in the JUPITER study (New England Journal of Medicine)
- Rosuvastatin and cardiovascular events in patients undergoing hemodialysis: the AURORA study (New England Journal of Medicine)
[podcast]http://www.npc.nhs.uk/podcast/ebt_300309.mp3[/podcast]
 |
Subscribe to the NPC podcast via the iTunes store |
 |
Subscribe to the NPC podcast via RSS feed |